3788577
Last Update Posted: 2023-04-14
Recruiting has ended
All Genders accepted | 50 Years + |
120 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Impact of Oligonol to Cardiometabolic Risk and Muscular Health
This project will mainly focus on Middle and old-aged adults, and examine whether Cardiovascular and metabolic risks can be reduced. In the meanwhile, this project will develop strategies for improving muscle loss , muscle strength decline, and the quality life of the elderly.
Cardiovascular diseases are common among the elder. However, previous researches mainly focus on observational research or small scale clinical trial, and the subjects are mainly youth. Therefore, this project hope to understand whether Oligonol can reduce Cardiovascular and metabolic risks among senior adults. Consequently,improve muscle loss muscle strength decline, quality of old adults life. This project design may potentially develop new strategies for curing Sarcopenia as well.
Eligibility
Relevant conditions:
Muscle Loss
Muscle Weakness
Quality of Life
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov